CNSP — CNS Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for CNS Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	14	5	10.1	0.549	6.46
Net Total Receivables	—	—	—	—	0.883
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15.5	7.48	12.6	1.59	8.66
Net Property, Plant And Equipment	0.023	0.016	0.006	0.005	0.006
Other Long Term Assets
Total Assets	15.9	8.76	13.1	1.7	8.7
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.91	2.59	4.92	6.13	2.52
Total Long Term Debt
Total Debt
Total Liabilities	1.91	2.59	4.92	6.13	2.52
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	13.9	6.16	8.13	-4.43	6.18
Total Liabilities & Shareholders' Equity	15.9	8.76	13.1	1.7	8.7
Total Common Shares Outstanding